PubMed:22751464 / 1231-1578 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T64 0-11 D018450 denotes Progression
T65 0-11 D018450 denotes Progression
T66 38-44 UBERON:0000310 denotes breast
T67 38-51 D001943 denotes breast cancer
T68 38-51 D001943 denotes breast cancer
T70 155-159 CVCL_5552 denotes DCIS
T69 155-159 D002285 denotes DCIS
T71 155-159 D002285 denotes DCIS
T111 173-191 P0DM47 denotes protease inhibitor
T113 173-191 P84885 denotes protease inhibitor
T115 173-191 P61153 denotes protease inhibitor
T117 173-191 P43131 denotes protease inhibitor
T118 173-191 P26228 denotes protease inhibitor
T112 173-191 CHEBI:60258 denotes protease inhibitor
T114 173-191 D011480 denotes protease inhibitor
T116 173-191 D011480 denotes protease inhibitor
T119 173-191 CHEBI:37670 denotes protease inhibitor
T121 193-197 PR:P56567 denotes CSTA
T122 193-197 PR:000022346 denotes CSTA
T123 193-197 PR:000005973 denotes CSTA
T124 193-197 PR:P01039 denotes CSTA
T125 193-197 PR:P15078 denotes CSTA
T126 193-197 PR:P01040 denotes CSTA
T127 221-234 GO:0007155 denotes cell adhesion
T128 239-248 GO:0023052 denotes signaling
T133 250-254 PR:000007350 denotes FAT1
T134 250-254 PR:Q14517 denotes FAT1
T135 250-254 PR:P38225 denotes FAT1
T136 250-254 PR:O13735 denotes FAT1
T137 250-254 PR:Q9NEQ0 denotes FAT1
T138 256-259 PR:Q91ZU6 denotes DST
T139 256-259 PR:Q03001 denotes DST
T140 256-259 P07631 denotes DST
T142 256-259 PR:000031275 denotes DST
T141 256-259 CHEBI:38291 denotes DST
T143 265-272 PR:000029808 denotes TMEM45A
T144 265-272 PR:Q9NWC5 denotes TMEM45A
T145 265-272 PR:Q60774 denotes TMEM45A

DisGeNET

Id Subject Object Predicate Lexical cue
T0 193-197 gene:1475 denotes CSTA
T1 29-51 disease:C0853879 denotes invasive breast cancer
T2 250-254 gene:2195 denotes FAT1
T3 29-51 disease:C0853879 denotes invasive breast cancer
T4 250-254 gene:2195 denotes FAT1
T5 155-159 disease:C0007124 denotes DCIS
T6 256-259 gene:667 denotes DST
T7 29-51 disease:C0853879 denotes invasive breast cancer
T8 265-272 gene:55076 denotes TMEM45A
T9 29-51 disease:C0853879 denotes invasive breast cancer
T10 265-272 gene:55076 denotes TMEM45A
T11 155-159 disease:C0007124 denotes DCIS
R1 T0 T1 associated_with CSTA,invasive breast cancer
R2 T2 T3 associated_with FAT1,invasive breast cancer
R3 T4 T5 associated_with FAT1,DCIS
R4 T6 T7 associated_with DST,invasive breast cancer
R5 T8 T9 associated_with TMEM45A,invasive breast cancer
R6 T10 T11 associated_with TMEM45A,DCIS

Allie

Id Subject Object Predicate Lexical cue
SS1_22751464_8_0 135-191 expanded denotes clinical samples of DCIS, including a protease inhibitor
SS2_22751464_8_0 193-197 abbr denotes CSTA
AE1_22751464_8_0 SS1_22751464_8_0 SS2_22751464_8_0 abbreviatedTo "clinical samples of DCIS, including a protease inhibitor",CSTA

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T8 0-347 DRI_Background denotes Progression of xenografts to invasive breast cancer was dramatically increased by suppressing four genes that were usually elevated in clinical samples of DCIS, including a protease inhibitor (CSTA) and genes involved in cell adhesion and signaling (FAT1, DST, and TMEM45A), strongly suggesting that they normally function to suppress progression.

PubmedHPO

Id Subject Object Predicate Lexical cue
T13 38-51 HP_0003002 denotes breast cancer
T14 38-51 HP_0100013 denotes breast cancer
T15 45-51 HP_0002664 denotes cancer